COVID-19 LATEST NEWS

Today, EMA has recommended COVID-19 Vaccine Janssen for authorisation in the EU.

Today, EMA has recommended COVID-19 Vaccine Janssen for authorisation in the EU.
March 11, 2021

Good news regarding the fight against the Covid-19 pandemic! Today, EMA has recommended COVID-19 Vaccine Janssen for authorisation in the EU. This will be the fourth vaccine against SARS-CoV-2 to be authorized in Europe, which shall speed up the vaccination process along the continent.

Additionally, EMA has also started today the rolling review of the monoclonal antibodies bamlanivimab and etesevimab (Eli Lilly). With this, there will be already three different treatments against COVID-19 under evaluation.

Stay tuned to be updated on all regulatory news related to COVID-19!

For further information you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

siNPAIN project | 2nd progress meeting

The siNPAIN project objective is to create a siRNA-combined advanced therapy, which will lead to more personalised treatment options for different stages of osteoarthritis.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting